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Background: To describe the clinicopathologic profile of young patients with head and neck squamous cell carci-
noma (HNSCC) and compare to middle-aged and elderly adults.
Material and Methods: Patients’ individual records were reviewed for clinicopathologic data. Eighty-nine patients 
with age 18-45 years old met the inclusion criteria of the study. Two additional groups of middle-aged (n=89) and 
old (n=89) adults were set to comparative analysis.
Results: Young patients represented 11.9% of all patients diagnosed with HNSCC. Women were more affected by 
HNSCC in the young and elder groups (p= 0.04), and young patients were more prone to be non-smokers (p= 0.01) 
and have lymph node metastasis at the time of diagnosis (p=0.04). In the young group, patients diagnosed with 
the disease in advanced stages were more prone to have a positive familial history of cancer (p= 0.04), a positive 
status of alcohol consumption (p= 0.03), and to be heavy drinkers (p= 0.01). Survival was not different for the 
young group in comparison to the other groups.
Conclusions: HNSCC in young patients had a different profile when compared to older patients, especially regard-
ing sex and exposure to the classic risk factors for this disease. The survival of the young group is similar to the 
older groups and advanced clinical stage is predictor of worse survival.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) 
is one of the most common human cancers and has a 
poor prognosis, representing an important public health 
problem worldwide (1,2). The profile of people affect-
ed by HNSCC is classically represented by men older 
than 50-years old (3). Incidence rates and the clinico-
pathologic profile of patients affected by HNSCC may 
vary among different geographic regions (4). These dif-
ferences might be due to different behavioral profiles 
regarding the risk factors for the disease (tobacco and 
alcohol) in different cultures (4).
HNSCC has a low incidence in people younger than 
45-years-old (5,6). This is possibly explained by the fact 
that young patients are not exposed to tobacco and alco-
hol in the same intensity and duration as older patients 
(5,6). Based on the etiology and disease behavior, HN-
SCC in young people is considered a distinct pathologic 
entity by some researchers (6,7). Thus, other etiologic 
factors for this disease have been investigated in the 
young population with HNSCC (3). A higher prevalence 
of human papillomavirus (HPV) in HNSCC samples 
from young people compared to older has been reported 
(8-10). Despite many studies described the association 
of HNSCC in young people to other risk factors, most 
patients of this age-group are also exposed to tobacco 
and alcohol consumption (11-13).
In addition to understand the etiology of HNSCC in 
young people, the analysis of factors involved in their 
prognosis is of great relevance. Van Monsjou et al. (14) 
showed that disease-specific survival (DSS) did not 
differ between young and elderly individuals with HN-
SCC. However, overall survival (OS) was significantly 
better for young patients. HPV-positive HNSCC cas-
es had a better prognosis compared to HPV-negative 
cases (15), which seems to be more common among 
young patients. On the other hand, further evidence 
demonstrates a worse prognosis for young patients 
with HNSCC in comparison to that of elderly patients, 
suggesting a higher aggressiveness of the disease in 
the young (16).
There is an evident need for a better understanding of 
the occurrence of HNSCC in young patients regarding 
its etiologic background, clinicopathologic character-
istics and prognosis in different populations. Thus, in 
this paper, we describe the clinicopathologic charac-
teristics and prognostic profile of young patients with 




The study population was composed of all patients pre-
senting for diagnosis and treatment of HNSCC from 
January 1991 through December 2016 at the Oral On-
cology Center, Araçatuba Dental School, São Paulo 
State University - UNESP, Brazil. Patients were in-
cluded in the study if they had a diagnosis of oral (oral 
cavity) or oropharyngeal (oropharynx, hypopharynx, 
and larynx) squamous cell carcinoma (SCC). Exclu-
sion criteria were: have recurrent HNSCC, had under-
gone previous oncologic treatment, had a histopatho-
logic diagnosis of other diseases, and with tumors in 
the lips. The study group was composed of 89 patients 
younger than or 45-years-old diagnosed with HNSCC. 
A group composed of middle-aged HNSCC patients (46 
to 59-years-old) and other composed of elderly patients 
(>60-years-old) were selected for comparison with the 
younger group. To avoid skewness, both middle-aged 
and elderly groups were limited to 89 patients which 
were set by a systematic sampling system (17).
- Variables and data collection
The relevant variables were collected from the individ-
ual medical records of each patient, and the age-group 
variable was defined as the predictor variable. The fol-
lowing variables were defined as outcome variables: 
sex, race, location of the primary tumor, status and 
intensity of tobacco and alcohol consumption, familiar 
history of cancer, clinical stage according to the Ameri-
can Joint Committee on Cancer (AJCC), histologic 
grading as recommended by the World Health Organi-
zation (WHO), and survival time (in days).
The status of tobacco smoking and alcohol drinking 
were classified as: current smokers/drinkers and nev-
er-smokers/drinkers. The intensity of these habits was 
graded according to daily consumption in light (<10 
cigarettes / 1 alcohol dose), moderate (11-20 cigarettes 
/ 2 – 3 alcohol doses) and severe (>21 cigarettes / >4 al-
cohol doses) as previously recommended (18). Former 
smokers/drinkers and current smokers/drinkers were 
grouped in the same group as patients ever exposed to 
these risk factors. For statistics purposes, the clinical 
stage at the time of diagnosis was classified as: early 
stages (clinical stages I and II) and advanced stages 
(III and IV).
- Statistical analysis
Data was transferred to electronic table software (Mi-
crosoft Excel 2016®), and statistical analysis was per-
formed using EpiInfo 7.0 (Center for Diseases Con-
trol) software. Chi-square and Fisher’s exact tests were 
used to compare the clinicopathological characteris-
tics among the different HNSCC patients grouped by 
the age groups. Additionally, the same tests were used 
to assess the relationship of clinicopathologic charac-
teristics with the disease stage. To analyze the overall 
survival and disease-specific survival, survival time 
from the HNSCC patients treated between 1999 and 
2011 were included, and Kapplan-Meier method and 
log-rank test were used. p-values <0.05 were consid-
ered statistically significant.
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Results
- Epidemiology
A retrospective analysis of the patients’ files provided a 
total of 899 patients with HNSCC (excluding lip tumors), 
among which 107 (11.9%) were younger than 45-years-
old. Of those, 89 patients met the inclusion criteria of 
the study. The middle-aged and elderly groups were ad-
justed to the number of young patients. Therefore, 89 
patients were included in each age group. The annual in-
cidence was calculated based on all files of the Oral On-
cology Center, as demonstrated in Table 1. The higher 
incidence rates of HNSCC among young patients were 
observed in the years 1996 and 1997 (22.2%), and w null 
incidence was observed in the year 2008. Neither con-
stant increase nor decrease in the incidence of HNSCC 
in young people was observed along the last 26 years.
- Comparison of age groups
In the young group, 78 (87.6%) patients were men and 
11 (12.4%) were women, while 85 (95.5%) from the 
middle-aged were men and 4 (4.5%) were women, and 
in the old-aged group 75 (84.3%) were men, and 14 
(15.7%) were women, demonstrating that women were 
statistically more frequently affected by HNSCC in the 
young and elder groups than in the middle-aged group 
(p=0.04) (Table 2). Young patients were more likely to 
be neve-smokers (p= 0.01), to have tumors in the oral 
cavity (p= 0.04), and to have lymph node metastasis at 
the time of diagnosis (p= 0.04) (Table 2).
Race, familial history of cancer, tobacco smoking in-
tensity, alcohol consumption status and intensity, sub-
locations of the oral cavity, tumor size, presence of dis-
tant metastasis at the time of diagnosis, clinical stage 
and histologic grading of tumors did not differ among 
the groups (Table 2). Neither overall survival nor dis-
ease-specific survival significantly differed among the 
age-groups (Fig. 1).
Year Total (n) >60 (n) 46-59 (n) <45 (n) >60 (%) 46-59 (%) <45 (%)
1991 18 7 8 3 38.88 44.44 16.66
1992 12 7 3 2 58.33 25 16.66
1993 25 14 9 2 56 36 8
1994 28 10 14 4 35.71 50 14.28
1995 43 21 16 6 48.83 37.20 13.95
1996 36 14 14 8 38.88 38.88 22.22
1997 27 8 13 6 29.62 48.14 22.22
1998 46 19 19 8 41.30 41.30 17.39
1999 25 13 10 2 52 40 8
2000 29 12 13 4 41.37 44.82 13.79
2001 43 23 11 9 53.48 25.58 20.93
2002 35 14 19 2 40 54.28 5.71
2003 29 13 12 4 44.82 41.37 13.79
2004 38 18 14 6 47.36 36.84 15.78
2005 34 13 16 5 38.23 47.05 14.70
2006 20 11 8 1 55 40 5
2007 32 16 10 6 50 31.25 18.75
2008 35 13 22 0 37.14 62.85 0
2009 28 14 13 1 50 46.42 3.57
2010 37 17 13 7 45.94 35.13 18.91
2011 49 13 18 6 26.53 36.73 12.24
2012 44 20 21 3 45.45 47.72 6.81
2013 37 17 17 3 45.94 45.94 8.10
2014 48 20 23 5 41.66 47.91 10.41
2015 53 24 27 2 45.28 50.94 3.77
2016 48 22 24 2 45.83 50 4.16
TOTAL 899 393 387 107 43.71 43.04 11.9
Table 1: Incidence of HNSCC stratified by year for different age groups.
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  Male 78 (87.6) 85 (95.5) 75 (84.3)
  Female 11 (12.4) 4 (4.5) 14 (15.7)
Race 0.109
  White 61 (68.5) 68 (76.4) 73 (82.0)
  Non-white 28 (31.5) 21 (23.6) 16 (18.0)
Familial history of cancer 0.130
  Yes 45 (51.7) 35 (41.2) 31 (36.9)
  No 42 (48.3) 50 (58.8) 53 (63.1)
Tobacco smoking status 0.015*
  Smoker 76 (87.4) 84 (98.8) 77 (90.6)
  Non-smoker 11 (12.6) 1 (1.2) 8 (9.4)
Tobacco smoking intensity 0.612
  Light 5 (7.1) 6 (7.4) 9 (12.9)
  Moderate 22 (31.4) 29 (35.8) 19 (27.1)
  Heavy 43 (61.4) 46 (56.8) 42 (60)
Alcohol drinking status 0.073
  Drinker 76 (87.4) 73 (85.9) 64 (75.3)
  Never drinker 11 (12.6) 12 (14.1) 12 (24.7)
Alcohol drinking intensity 0.827
  Light 9 (13.2) 10 (14.9) 10 (16.9)
  Moderate 32 (47.1) 29 (43.3) 30 (50.8)
  Heavy 27 (39.7) 28 (41.8) 19 (32.22)
Tumor site 0.049*
  Oral cavity 51 (38.6) 46 (34.8) 35 (26.5)
  Oropharyngeal 38 (28.1) 43 (31.8) 54 (40)
Sublocations for oral cavity 0.336
  Border of tongue 20 (39.2) 13 (28.3) 13 (37.1)
  Floor of mouth 18 (35.3) 17 (37.0) 8 (22.9)
  Buccal mucosa 2 (3.9) 3 (6.5) 2 (5.7)
  Belly of tongue 0 (0.0) 0 (0.0) 2 (5.7)
  Alveolar ridge 6 (11.8) 5 (10.9) 7 (20.0)
  Retromolar pad 4 (7.8) 8 (17.4) 3 (8.6)
  Hard palate 1 (2.0) 0 (0.0) 0 (0.0)
Tumor size 0.520
  T1/T2 34 (39.0) 38 (46.3) 33 (39.2)
  T3/T4 53 (60.9) 44 (53.6) 51 (60.7)
Lymph node metastasis 0.044*
  Negative 40 (45.9) 48 (58.5) 55 (63.9)
  Positive 47 (54) 34 (41.4) 31 (36)
Distant metastasis 0.132
  Yes 10 (11.5) 8 (9.8) 3 (3.5)
  No 77 (88.5) 74 (90.2) 83 (96.5)
Clinical stage 0.428
  Early (I and II) 24 (27.0) 27 (32.5) 31 (36.0)
  Advanced (III and IV) 65 (73.0) 56 (67.5) 55 (64.0)
Histologic grade (WHO) 0.439
  1 26 (30.2) 15 (20.5) 16 (21.3)
  2 54 (62.8) 50 (68.5) 49 (65.3)
  3 6 (7.0) 8 (11.0) 10 (13.3)
*Statistically significant (p<0.05)
Table 2: Comparison of clinicopathologic characteristics between young-adults, middle-age adults, and old-aged adults with HNSCC.
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- Clinicopathologic characteristics of HNSCC in young 
patients
The clinicopathologic profile of the HNSCC in the young 
group was studied separately. A familial history of can-
cer was significantly associated with the diagnosis of 
HNSCC in the early stages (p= 0.03) (Table 3). Patients 
with positive status of alcohol consumption were more 
prone to present with the disease in advanced stages (p= 
0.03). The same was observed for heavy drinkers (p= 
0.01) (Table 3).
Sex, race, tobacco smoking status and intensity, tumor 
location and histologic grade were neither associated to 
initial nor to advanced clinical stages.
We compared the clinicopathologic variables of the 
young group by tumor location (Table 4). There was no 
difference between the oral cavity and oropharyngeal 
tumors regarding sex, familial history of cancer, race, 
tobacco smoking status, tobacco smoking intensity, al-
cohol drinking status, tumor size, distant metastasis, 








  M 20 (83,3) 58 (89,2)
  F 4 (16,7) 7 (10,8)
Familial history of cancer 0,0389**
  Yes 16 (69,6) 29 (45,3)
  No 7 (30,4) 35 (54,7)
Race
  White 19 (79,2) 42 (64,6) 0,1453**
  Non-white 5 (20,8) 23 (35,4)
Tobacco smoking status 0,1239*
  Smoker 18 (78.3) 58 (90.6)
  Non-smoker 5 (21.7) 6 (9.4)
Tobacco smoking intensity 0,1643*
  Light 0 (0,0) 5 (9,4)
  Moderate 8 (47,1) 14 (26,4)
  Heavy 9 (52,9) 34 (64,2)
Alcohol drinking status 0,0338*
  Drinker 17 (73.9) 59 (92.2)
  Non-drinker 6 (26.1) 5 (7.8)
Alcohol drinking intensity 0.0147*
  Light 2 (14,3) 7 (13,0)
  Moderate 11 (78,6) 21 (38,9)
  Heavy 1 (7,1) 26 (48,1)
Tumor location 0.116*
  Oral cavity 17 (33.33) 34 (66.6)
  Oropharyngeal 7 (18.4) 31 (81.5)
Mouth sublocations 0,1205*
  Border of tongue 9 (52,9) 11 (32,4)
  Floor of mouth 8 (47,1) 10 (29,4)
  Buccal Mucosa 0 (0,0) 2 (5,9)
  Belly of tongue 0 (0,0) 0 (0,0)
  Alveolar Ridge 0 (0,0) 6 (17,6)
  Retromolar pad 0 (0,0) 4 (11,8)
  Hard Palate 0 (0,0) 1 (2,9)
Histologic Grade 0,1446*
  Well differentiated 10 (41,7) 16 (25,8)
  Moderately differentiated 14 (58,3) 40 (64,5)
  Poorly differentiated 0 (0,0) 6 (9,7)
*Chi-square test
**Fisher’s exact test
Table 3: Association of clinicopathologic characteristics to clinical stage of Young patient with HNSCC.
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tumors had more lymph node metastasis (p<0.01) and 
poorly differentiated SCC (p=0.01). Young patients 
with oropharyngeal tumors were more likely to be 
heavy alcohol drinkers (p=0.02).
Advanced stages of the HNSCC in young patients were 








  M 45 (88.2) 33 (86.8)
  F 6 (11.7) 5 (13.1)
Familial history of cancer 0.560*
  Yes 24 (48.9) 21 (55.2)
  No 25 (51) 17 (44.7)
Race 0.983*
  White 35 (68.6) 26 (68.4)
  Non-white 16 (31.3) 12 (31.5)
Tobacco smoking status 0,199**
  Smoker 41 (83.6) 35 (92.1)
  Non-smoker 8 (16.3) 3 (7.8)
Tobacco smoking intensity 0,128*
  Light 3 (8.1) 2 (6)
  Moderate 15 (40.5) 7 (21.2)
  Heavy 19 (51.3) 24 (72.7)
Alcohol drinking status 0.573**
  Drinker 43 (87.7) 33 (86.8)
  Non-drinker 6 (12.2) 5 (13.1)
Alcohol drinking intensity 0.029*
  Light 8 (20.5) 1 (3.4)
  Moderate 20 (51.2) 12 (41.3)
  Heavy 11 (28.2) 16 (55.1)
Tumor size 0.677*
  T1/T2 19 (37.2) 15 (41.6)
  T3/T4 32 (62.7) 21 (58.3)
Lymph Note Metastasis 0.004*
  Negative (N0) 30 (58.8) 10 (27.7)
  Positive (N1-N3) 21 (41.1) 26 (72.2)
Distant Metastasis 0.397**
  Yes 46 (90.2) 31 (86.1)
  No 5 (9.8) 5 (13.8)
Clinical Stage 0.166*
  Initial (I-II) 17 (33.3) 7 (18.4)
  Advanced (III-IV) 34 (66.6) 31 (81.5)
Histologic Grade 0.019*
  Well differentiated 21 (41.1) 5 (14.2)
  Moderately differentiated 28 (54.9) 26 (74.2)
  Poorly differentiated 2 (3.9) 4 (11.4)
*Chi-square test
**Fisher’s exact test
(Fig. 1). Survival was not different between young pa-
tients with oral cavity and oropharyngeal HNSCC (p= 
0.7) (Fig. 1). Tobacco smoking, alcohol consumption 
status, familial history of cancer and histologic grade 
had no significant influence on the survival of HNSCC 
young patients.
Table 4: Association of clinicopathologic characteristics to tumor location of Young patient with HNSCC.
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Discussion
In the present 26-year retrospective study accessing data 
from a single specialized cancer center in the southeast 
region of Brazil, 899 cases of HNSCC (excluding lips) 
were found, of which 107 (11.9%) were diagnosed in 
patients younger than 45-years-old. In general, the oral 
cavity is the region of the head and neck most common-
ly affected by SCC (1,2). In the present cohort, young 
patients were more prone to have oral cavity tumors, 
while elder patients were mostly affected by oropharyn-
geal tumors (Table 2). Most studies with young patients 
have focused the analysis only in SCC of the oral cavity 
(5). In the current study, there was no significant dif-
ference among the age groups regarding sublocations 
of the oral cavity, which is in accordance with previous 
investigations (19,20). In contrast, Troeltzsch et al. (17) 
observed that the oral tongue was significantly more af-
fected in the young group than in the middle-aged and 
elder groups.
The incidence of oral SCC (OSCC) in young people is 
relatively low and varies depending on the geographic 
region (5). Estimates for OSCC in people <45-years-old 
for the North and South Americas are respectively 5.4% 
and 5.7% (5) of all OSCC cases. The incidence of OSCC 
found in the present study corroborates with further 
Brazilian cohorts (11,13) and approximates to cohorts 
from Africa (17.2%) and Middle East countries (14.5%) 
(5). Increases in the incidence of OSCC in young people 
have been observed in several regions, especially in 
Western countries, along with a decrease in the inci-
dence rates for people of the classic profile for this dis-
ease (5). However, an important decrease in the preva-
lence of young people with OSCC along the last years 
was observed in a recent Brazilian report (13). The lack 
of constant decrease and increase in the incidence of 
HNSCC in young people observed in the present study 
does not confirm this data. Wider epidemiological mul-
ticenter studies are required to clarify the regions in 
which there is a growth in the incidence of HNSCC in 
young people.
HNSCC is known to have a notorious predilection for 
occurring in men (2). Therefore, the female group might 
be the target for deeper investigations. We observed that 
the proportion of female patients with HNSCC was sig-
nificantly higher in the young and elderly groups than in 
the middle-aged group. In France, Blanchard et al. (21) 
did not find a significant difference between age-groups 
regarding sex, similar to two previous Brazilian cohorts 
Fig. 1: (A) Overall survival (OS) for the three age groups (p= 0.9). (B) Disease-specific survival (DSS) for the three age groups (p= 0.6). (C) 
Disease-specific survival (DSS) of young patients according to clinical stage (p= 0.02). (D) Disease specific survival (DSS) for oral and oropha-
ryngeal squamous cell carcinoma in the young patients (p= 0.7).
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(19,20). These studies did not segregate the sample in 
three age groups as in the present study, thus young 
patients were only compared to patients >45-years-old. 
However, Santos et al. (13), demonstrated that in a pop-
ulation from the northwest region of Brazil, the propor-
tion of female patients in the young group (18.4%) was 
higher than in the present cohort (12.4%), while Troelt-
zsch et al. (17) did not observe significant differences 
regarding sex among three age groups in Germany. We 
believe that the difference in sex distribution among the 
age-groups observed in the present study is mostly in-
fluenced by the higher occurrence of HNSCC in elderly 
women. The HNSCC in elderly women is also believed 
to be a distinct disease by some researchers, and is re-
cently being target for deeper investigation, including 
in our center.
Epidemiological trends for HNSCC in young people 
might be determined by a distinct etiologic background 
(5-7). Although most patients in all groups of the cur-
rent study were smokers, more patients from the young 
group were never exposed to this habit (Table 2), cor-
roborating with other studies from Brazil (9), The Neth-
erlands (14), and China (22). Toporcov et al. (23) did 
not observe any differences in alcohol and tobacco con-
sumption between young and older patients. However, 
attributable fractions (AF) for smoking and drinking 
were lower for young patients, suggesting that differ-
ences in etiologic factors for HNSCC may indeed exist 
(23). Curiously, we did not observe a significant associa-
tion of the status of tobacco smoking with the disease 
stage for young patients, which was observed for alcohol 
drinking status and intensity. Santos et al. (13) observed 
a significant association of harmful habits (tobacco and 
alcohol consumption) with advanced clinical stages of 
young patients with OSCC, however, these factors were 
not evaluated separately. Nevertheless, due to the short 
time of exposure, there remain doubts regarding the role 
of tobacco and ethanol as risk factors for HNSCC in 
young people (24).
Although most of the young patients were exposed to the 
classic risk factors for HNSCC, the risk factors for this 
disease and its progression in this specific group is not 
fully compatible with those for older patients, deserving 
deeper investigations. The only study that investigated 
in molecular level the expression of enzymes involved 
in the biotransformation of tobacco and alcohol did not 
demonstrate great differences between young and older 
patients (24). However, the pathways involved in the 
carcinogenesis induced by alcohol and tobacco in young 
patients still require investigations.
Halboub et al. (25) observed that young patients were 
significantly more prone to have lymphatic metastasis at 
the time of diagnosis and poorly differentiated OSCC. 
In the present cohort, although we did not observe dif-
ferences regarding the histologic grade of tumors, the 
young patients had more lymph node metastasis than 
the other groups. Although tumor size and histologic 
grade of the primary tumor were not different for young 
patients, the tumors of this group seem to have a higher 
potential to spread to local lymph nodes. The evidence 
regarding the biological behavior of HNSCC in young 
patients is scarce, however, VEGF-C, Podoplanin, and 
MMP-9 were more expressed in OSCC of young patients 
in previous studies (26-28). Although these proteins are 
involved in lymphatic growth and local invasion, nei-
ther clinical stage nor lymph node status was different 
for young patients, and lymph node positivity was not 
dependent on the overexpression of these proteins (26-
28). Further investigations should focus on the tumor 
lymph node spread mechanisms in young patients.
There is no consensus if the HNSCC in young people 
has a more aggressive behavior than in older people. 
Naz et al. (29), Blanchard et al. (21), and Frare et al. 
(19) neither found significant differences in the clinical 
parameters of tumors nor differences in the histological 
grading of tumors between young and older patients, 
corroborating with our findings. Although in a study by 
Kaminagakura et al. (24) there was no discrepancy be-
tween age groups regarding clinical staging, the young 
patients had more undifferentiated OSCC than the older 
patients, as also observed by Halboub et al. (25). The 
treatment decision for HNSCC is based mostly on the 
clinical staging classification. Nevertheless, although 
many studies show that the clinical stage for young pa-
tients is not different from older patients, the molecu-
lar profile of tumors in this population might reflect a 
distinct entity (6) and requires further investigation in 
order to enable the treatment individualization.
Despite the recent efforts to promote early detection, 
most HNSCC patients still experiment poor survival 
(1,2). Frare et al. (19) indicated that young patients with 
HNSCC had a worse prognosis than older patients. On 
the other hand, Camillon et al. (30) observed a signifi-
cant worsening of survival along with the increasing of 
age in patients with SCC of the oropharynx. In a study 
by Van Monsjou et al. (14) patients older than 40-years 
old had worse overall survival than patients younger 
than 40-years old. In the present cohort, there were no 
significant differences either on overall survival or on 
disease-specific survival among the three age groups, 
in agreement with Zhang et al. (22). Worse survival for 
young patients with HNSCC is believed to be due to 
differences in the etiologic background (6). However, 
although in this study we observed that young patients 
were less exposed to tobacco smoking, this group did 
not have worse survival, and neither tobacco smoking 
nor alcohol drinking influenced survival.
Our findings show that young patients with HNSCC 
were less prone to be smokers than middle-aged and 
elder patients. The survival profile for the young group 
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was similar to the older groups. Multicenter studies are 
required to clarify geographic and cultural influences 
on the occurrence of HNSCC in the young population. 
In addition, the role of further etiologic factors and tu-
mor behavioral biomarkers must be judiciously studied 
in the young population with HNSCC, in order to allow 
better prevention, treatment strategies, and survival im-
provement.
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